Name: 글로벌 시장 동향
SKU: PH3873
Availability: InStock

보고서 요약(국문)

보고서 개요
글로벌 파라세타몰 시장은 2023년 105억 달러에 달했으며, 2024년부터 2031년까지 연평균 4.3%의 성장률을 보이며 2031년에는 1,459만 달러에 이를 것으로 예상됩니다.
파라세타몰(아세트아미노펜)은 비마약성 진통제 및 해열제로, 발열과 경증에서 중등도의 통증 치료에 사용됩니다. 널리 사용되는 일반의약품이며, 대표적인 브랜드로는 타이레놀과 파나돌이 있습니다. 파라세타몰은 급성 경증 편두통과 삽화성 긴장성 두통 모두에서 통증을 완화시켜 줍니다.
아스피린/파라세타몰/카페인 복합제 또한 경증 편두통에 효과적이며, 이러한 질환의 1차 치료제로 권장됩니다. 파라세타몰은 수술 후 통증에 효과적이지만 이부프로펜보다 효과가 떨어집니다. 파라세타몰과 이부프로펜을 병용하면 효능이 더욱 향상되어 각 약물 단독 사용보다 우수합니다.
시장 동향: 성장 요인
발열 및 통증 관련 질환의 증가
발열 및 통증 관련 질환의 증가 추세가 시장 성장을 견인하고 있습니다. 예를 들어, 미국 질병통제예방센터(CDC)에 따르면 매년 전 세계적으로 약 1,100만~2,100만 건의 장티푸스와 500만 건의 파라티푸스가 발생하며, 이로 인해 약 13만 5천~23만 명이 사망하는 것으로 추정됩니다. 미국에서는 매년 배양 검사를 통해 확진된 장티푸스 환자 400명과 파라티푸스 A형으로 인한 파라티푸스 환자 50~100명이 보고되고 있으며, 파라티푸스 B형과 C형으로 인한 파라티푸스는 드물게 보고됩니다.

미국에서 발생하는 장티푸스의 약 85%와 파라티푸스의 약 92%는 해외 여행객에게서 발생하며, 특히 방글라데시, 인도, 파키스탄 등 남아시아에서 귀국한 여행객이 대부분입니다. 아프리카, 라틴 아메리카, 동남아시아 또한 감염 위험이 높은 지역이며, 동아시아와 카리브해 지역은 상대적으로 위험도가 낮은 지역입니다. 발열 및 통증 관련 질환의 증가 추세는 파라세타몰 시장 성장의 주요 동력입니다.
제약 요인
파라세타몰의 부작용은 시장 성장을 저해할 것으로 예상됩니다. 피부 부종, 졸음, 빠른 심박수, 혈압 상승 등의 부작용이 일부 사례에서 관찰됩니다.
시장 세분화 분석
세계 파라세타몰 시장은 제형, 용도, 유통 채널, 지역별로 세분화됩니다.
정제 제형은 세계 파라세타몰 시장의 약 47%를 차지합니다.
정제 제형은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 이 부문에서는 기술 발전과 민간 제조업체의 연구 개발 투자 증가가 시장 성장을 견인할 것입니다.
파라세타몰 정제는 복용이 간편하여 가장 널리 사용되는 제형 중 하나입니다. 예를 들어, 2023년 7월 Granules India는 Advil Dual Action 정제의 일반의약품(OTC) 버전에 대해 미국 식품의약국(FDA)의 승인을 받았습니다. 승인된 의약품은 아세트아미노펜과 이부프로펜 정제로, 250mg/125mg 용량이며 일반의약품(OTC)으로 구입할 수 있습니다.
시장 지역별 점유율
북미는 전 세계 파라세타몰 시장의 약 42%를 차지했습니다.
북미 지역은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 이 지역에서 발열 및 통증 관련 질환 발생률 증가와 기술 발전이 시장 성장을 촉진할 것입니다.

예를 들어, 2023년 10월 HealthDay News에 게재된 기사에 따르면 관절염은 미국 성인의 21%, 즉 5,300만 명 이상에게 영향을 미치는 대중적인 질병이 되고 있습니다. 전체 관절염 환자의 약 88%는 45세 이상 성인이었고, 약 50%는 18세에서 64세 사이의 근로 연령층이었습니다. 만성 폐쇄성 폐질환(COPD) 환자의 약 58%, 치매 환자의 56%, 뇌졸중 환자의 53%, 심장 질환 환자의 52%가 관절염을 앓고 있습니다. 장애가 있는 성인의 약 55%가 관절염을 앓고 있습니다.
또한, 골관절염 행동 연합(OAAA)에 따르면, 미국 질병통제예방센터(CDC)는 미국 성인 5명 중 1명(5,320만 명)이 어떤 형태로든 관절염을 앓고 있다고 추정합니다. 관절염의 종류는 100가지가 넘는 것으로 추정되지만, 골관절염(OA)은 가장 흔한 형태의 관절염으로, 미국 성인 3,250만 명에게 영향을 미칩니다. 골관절염 환자의 62%는 여성입니다.
시장 세분화
제형별
정제
캡슐
기타
적용 분야별
감기 및 기침
두통 및 발열
근육 경련
기타
유통 채널별
병원 약국
소매 약국
온라인 약국
기타
지역별
북미
미국
캐나다
멕시코
유럽
독일
영국
프랑스
스페인
이탈리아
기타 유럽 지역
남미
브라질
아르헨티나
기타 남미 지역
아시아 태평양
중국
인도
일본
한국
기타 아시아 태평양 지역
중동 및 아프리카
시장 경쟁 환경
세계 파라세타몰 시장의 주요 글로벌 업체로는 GlaxoSmithKline Plc., Teva Pharmaceuticals Inc., Genesis Biotec Inc., Mallinckrodt Pharmaceuticals, Abbott, Pfizer Inc., Johnson & 존슨 서비스(Johnson Services Inc.), 시플라(Cipla), 닥터 레디스 래버러토리스(Dr. Reddy’s Laboratories Ltd.), 사노피(Sanofi) 등이 주요 기업입니다.
주요 개발 사항
2024년 8월, 글로벌 자가 관리 제품 기업 페리고(Perrigo)는 자사의 첫 번째 고용량 1000mg 파라세타몰 발포정인 솔파원(SolpaOne®)을 출시했습니다. 이 제품은 성인 경구 진통제 분야에서 솔파데인(Solpadeine®) 포트폴리오를 확장하는 최신 제품입니다.
2024년 6월, 통증과 발열 완화에 효과적인 500mg 파라세타몰 BP 정제인 멜돌(Meldol)이 샌즈 액티브(Sands Active Pvt. Ltd.)에 의해 공식 출시되었습니다.
보고서 구매 이유
제형, 용도, 유통 채널 및 지역별 글로벌 파라세타몰 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위함입니다.
트렌드 분석 및 공동 개발을 통해 사업 기회를 식별하기 위함입니다.
모든 세그먼트를 포함한 글로벌 파라세타몰 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트입니다.

보고서 구매 이유 PDF 보고서는 철저한 질적 인터뷰와 심층 연구를 바탕으로 한 종합적인 분석 결과를 담고 있습니다.
주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑은 Excel 파일로 제공됩니다.
글로벌 파라세타몰 시장 보고서는 약 51개의 표, 54개의 그림, 그리고 181페이지 분량으로 구성됩니다.
주요 독자층 (2024년 기준)
제조업체/구매자
산업 투자자/투자은행가
연구 전문가
신흥 기업

보고서 요약(영어 원문)

Report Overview
Global Paracetamol Market reached US$ 10.5 billion in 2023 and is expected to reach US$ 14.59 million by 2031, growing at a CAGR of 4.3% during the forecast period 2024-2031.
Paracetamol (acetaminophen) is a non-opioid analgesic and antipyretic agent used to treat fever and mild to moderate pain. It is a widely used over-the-counter medication. Common brand names include Tylenol and Panadol. Paracetamol relieves pain in both acute mild migraine and episodic tension headache.
The aspirin/paracetamol/caffeine combination also helps with both conditions where the pain is mild and is recommended as a first-line treatment for them. Paracetamol is effective for post-surgical pain, but it is inferior to ibuprofen. The paracetamol/ibuprofen combination provides further increase in potency and is superior to either drug alone.
Market Dynamics: Drivers
Increasing prevalence of fever and pain-related disorders
The rising prevalence of fever and pain-related disorders propels the market growth. For instance, according to the CDC, an estimated 11–21 million cases of typhoid fever and 5 million cases of paratyphoid fever occur worldwide each year, causing an estimated 135,000–230,000 deaths. In the United States 400 culture-confirmed cases of typhoid fever and 50–100 cases of paratyphoid fever caused by Paratyphi A were reported each year; paratyphoid fever caused by Paratyphi B and Paratyphi C is rarely reported.
Approximately 85% of typhoid fever and 92% of paratyphoid fever cases in the United States occur among international travelers; most are in travelers returning from South Asia, primarily Bangladesh, India, and Pakistan. Other high-risk regions for infection include Africa, Latin America, and Southeast Asia; lower-risk regions include East Asia and the Caribbean. The increase in the number of fevers, pain related disorders acts as a major driving factor for paracetamol market.
Restraints
Factors such as side effects associated with paracetamol are expected to hamper the market. Side effects such as swelling of the skin, drowsiness, rapid heartbeat, and increased blood pressure are observed in some cases.
Market Segment Analysis
The global paracetamol market is segmented based on dosage form, application, distribution channel, and region.
The segment tablet accounted for approximately 47% of the global paracetamol market share
The tablet segment is expected to hold the largest market share over the forecast period. In this segment, technological advancements, and rising funds for private manufacturers for research work would drive this market.
The tablet form of paracetamol is one of the most widely used forms of paracetamol due to its ease of route of administration. For instance, in July 2023, Granules India received USFDA approval for the OTC equivalent of Advil Dual Action tablets. The approved drug is called Acetaminophen and Ibuprofen tablets, with a strength of 250 mg/125 mg, and it can be purchased over the counter (OTC).
Market Geographical Share
North America accounted for approximately 42% of the global paracetamol market share
North America region is expected to hold the largest market share over the forecast period. The rising incidence of fever and pain related disorders, and technological advancements, in this region, help to propel the market.
For instance, according to an article published by HealthDay News in October 2023, arthritis is becoming a disease of the masses, striking 21% of U.S. adults, or over 53 million people. About 88% of all arthritis cases were adults aged 45 and up, while about 50% were working-age people ranging in age from 18 to 64. About 58% of people who have COPD have arthritis, as do 56% of those with dementia, 53% who have had a stroke, and 52% with heart disease. About 55% of adults with a disability have arthritis.
Moreover, according to the Osteoarthritis Action Alliance (OAAA), the CDC estimates that 1 in 5 (or 53.2 million) US adults have some form of arthritis. While there are estimated to be more than 100 types of arthritis, osteoarthritis (OA) is the most common form of arthritis, affecting 32.5 million US adults. 62% of individuals with osteoarthritis are women.
Market Segmentation
By Dosage Form
Tablet
Capsules
Others
By Application
Cold and Cough
Headache and Fever
Muscle Cramps
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the global paracetamol market include GlaxoSmithKline Plc., Teva Pharmaceuticals Inc., Genesis Biotec Inc., Mallinckrodt Pharmaceuticals, Abbott, Pfizer Inc., Johnson & Johnson Services Inc., Cipla, Dr. Reddy’s Laboratories Ltd., Sanofi among others.
Key Developments
In August 2024, Global self-care company Perrigo launched SolpaOne®, its first maximum strength, 1000mg paracetamol in one effervescent tablet. The product is the latest in the expansion of its Solpadeine® pain portfolio in adult oral analgesics.
In June 2024, Meldol, a 500 mg Paracetamol BP tablet offering reliable relief from pain and fever, was officially launched by the manufacturing company Sands Active Pvt. Ltd.
Why Purchase the Report?
To visualize the global paracetamol market segmentation based on dosage form, application, distribution channel, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of global paracetamol market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.
The global paracetamol market report would provide approximately 51 tables, 54 figures, and 181 Pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Dosage Form
3.2. Snippet by Application
3.3. Snippet by Distribution Channel
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Prevalence of Fever and Pain Related Disorders
4.1.2. Restraints
4.1.2.1. Side Effects Associated with Paracetamol
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. By Dosage Form
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
6.1.2. Market Attractiveness Index, By Dosage Form
6.2. Tablet*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Capsules
6.4. Others
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Cold and Cough*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Headache and Fever
7.4. Muscle Cramps
7.5. Others
8. By Distribution Channel
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
8.1.2. Market Attractiveness Index, By Distribution Channel
8.2. Hospital Pharmacy*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Retail Pharmacy
8.4. Online Pharmacy
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. UK
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. GlaxoSmithKline Plc. *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Teva Pharmaceuticals Inc.
11.3. Genesis Biotec Inc.
11.4. Mallinckrodt Pharmaceuticals
11.5. Abbott
11.6. Pfizer Inc.
11.7. Johnson & Johnson Services Inc.
11.8. Cipla
11.9. Dr. Reddy’s Laboratories Ltd.
11.10. Sanofi (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us

언급된 주요 기업들

GlaxoSmithKline Plc., 4.	Key Developments, Teva Pharmaceuticals Inc., Genesis Biotec Inc., Mallinckrodt Pharmaceuticals, Abbott, Pfizer Inc., Johnson & Johnson Services Inc., Cipla, Dr. Reddy’s Laboratories Ltd.

표 목록 (Tables)

List of Tables

Table 1 Global Paracetamol Market Value, By Dosage Form, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Paracetamol Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Paracetamol Market Value, By Distribution Channel, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Paracetamol Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Paracetamol Market Value, By Dosage Form, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Paracetamol Market Value, By Dosage Form, 2022-2031 (US$ Million)

Table 7 Global Paracetamol Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Paracetamol Market Value, By Application, 2022-2031 (US$ Million)

Table 9 Global Paracetamol Market Value, By Distribution Channel, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Paracetamol Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 11 Global Paracetamol Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Paracetamol Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Paracetamol Market Value, By Dosage Form, 2022-2031 (US$ Million)

Table 14 North America Paracetamol Market Value, By Application, 2022-2031 (US$ Million)

Table 15 North America Paracetamol Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 16 North America Paracetamol Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Paracetamol Market Value, By Dosage Form, 2022-2031 (US$ Million)

Table 18 South America Paracetamol Market Value, By Application, 2022-2031 (US$ Million)

Table 19 South America Paracetamol Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 20 South America Paracetamol Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Paracetamol Market Value, By Dosage Form, 2022-2031 (US$ Million)

Table 22 Europe Paracetamol Market Value, By Application, 2022-2031 (US$ Million)

Table 23 Europe Paracetamol Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 24 Europe Paracetamol Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Paracetamol Market Value, By Dosage Form, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Paracetamol Market Value, By Application, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Paracetamol Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Paracetamol Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East and Africa Paracetamol Market Value, By Dosage Form, 2022-2031 (US$ Million)

Table 30 Middle East and Africa Paracetamol Market Value, By Application, 2022-2031 (US$ Million)

Table 31 Middle East and Africa Paracetamol Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 32 Middle East and Africa Paracetamol Market Value, By Country, 2022-2031 (US$ Million)

Table 33 GlaxoSmithKline Plc.: Overview

Table 34 GlaxoSmithKline Plc.: Product Portfolio

Table 35 GlaxoSmithKline Plc.: Key Developments

Table 36 Teva Pharmaceuticals Inc.: Overview

Table 37 Teva Pharmaceuticals Inc.: Product Portfolio

Table 38 Teva Pharmaceuticals Inc.: Key Developments

Table 39 Genesis Biotec Inc.: Overview

Table 40 Genesis Biotec Inc.: Product Portfolio

Table 41 Genesis Biotec Inc.: Key Developments

Table 42 Mallinckrodt Pharmaceuticals: Overview

Table 43 Mallinckrodt Pharmaceuticals: Product Portfolio

Table 44 Mallinckrodt Pharmaceuticals: Key Developments

Table 45 Abbott: Overview

Table 46 Abbott: Product Portfolio

Table 47 Abbott: Key Developments

Table 48 Pfizer Inc.: Overview

Table 49 Pfizer Inc.: Product Portfolio

Table 50 Pfizer Inc.: Key Developments

Table 51 Johnson & Johnson Services Inc.: Overview

Table 52 Johnson & Johnson Services Inc.: Product Portfolio

Table 53 Johnson & Johnson Services Inc.: Key Developments

Table 54 Cipla: Overview

Table 55 Cipla: Product Portfolio

Table 56 Cipla: Key Developments

Table 57 Dr. Reddy’s Laboratories Ltd.: Overview

Table 58 Dr. Reddy’s Laboratories Ltd.: Product Portfolio

Table 59 Dr. Reddy’s Laboratories Ltd.: Key Developments

Table 60 Sanofi: Overview

Table 61 Sanofi: Product Portfolio

Table 62 Sanofi: Key Developments 1 (US$ Million)

그림 목록 (Figures)

List of Figures

Figure 1 Global Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 2 Global Paracetamol Market Share, By Dosage Form, 2023 & 2031 (%)

Figure 3 Global Paracetamol Market Share, By Application, 2023 & 2031 (%)

Figure 4 Global Paracetamol Market Share, By Distribution Channel, 2023 & 2031 (%)

Figure 5 Global Paracetamol Market Share, By Region, 2023 & 2031 (%)

Figure 6 Global Paracetamol Market Y-o-Y Growth, By Dosage Form, 2023-2031 (%)

Figure 7 Cold and Cough Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 8 Headache and Fever Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 9 Muscle Cramps Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 10 Others Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 11 Global Paracetamol Market Y-o-Y Growth, By Application, 2023-2031 (%)

Figure 12 Tablet Application in Global Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 13 Capsules Application in Global Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 14 Others Application in Global Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 15 Global Paracetamol Market Y-o-Y Growth, By Distribution Channel, 2023-2031 (%)

Figure 16 Retail Pharmacies Distribution Channel in Global Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 17 Hospital Pharmacies Distribution Channel in Global Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 18 Online Pharmacies Distribution Channel in Global Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 19 Others Distribution Channel in Global Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 20 Global Paracetamol Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 21 North America Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 22 North America Paracetamol Market Share, By Dosage Form, 2023 & 2031 (%)

Figure 23 North America Paracetamol Market Share, By Application, 2023 & 2031 (%)

Figure 24 North America Paracetamol Market Share, By Distribution Channel, 2023 & 2031 (%)

Figure 25 North America Paracetamol Market Share, By Country, 2023 & 2031 (%)

Figure 26 South America Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 27 South America Paracetamol Market Share, By Dosage Form, 2023 & 2031 (%)

Figure 28 South America Paracetamol Market Share, By Application, 2023 & 2031 (%)

Figure 29 South America Paracetamol Market Share, By Distribution Channel, 2023 & 2031 (%)

Figure 30 South America Paracetamol Market Share, By Country, 2023 & 2031 (%)

Figure 31 Europe Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 32 Europe Paracetamol Market Share, By Dosage Form, 2023 & 2031 (%)

Figure 33 Europe Paracetamol Market Share, By Application, 2023 & 2031 (%)

Figure 34 Europe Paracetamol Market Share, By Distribution Channel, 2023 & 2031 (%)

Figure 35 Europe Paracetamol Market Share, By Country, 2023 & 2031 (%)

Figure 36 Asia-Pacific Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 37 Asia-Pacific Paracetamol Market Share, By Dosage Form, 2023 & 2031 (%)

Figure 38 Asia-Pacific Paracetamol Market Share, By Application, 2023 & 2031 (%)

Figure 39 Asia-Pacific Paracetamol Market Share, By Distribution Channel, 2023 & 2031 (%)

Figure 40 Asia-Pacific Paracetamol Market Share, By Country, 2023 & 2031 (%)

Figure 41 Middle East and Africa Paracetamol Market Value, 2022-2031 (US$ Million)

Figure 42 Middle East and Africa Paracetamol Market Share, By Dosage Form, 2023 & 2031 (%)

Figure 43 Middle East and Africa Paracetamol Market Share, By Application, 2023 & 2031 (%)

Figure 44 Middle East and Africa Paracetamol Market Share, By Distribution Channel, 2023 & 2031 (%)

Figure 45 GlaxoSmithKline Plc.: Financials

Figure 46 Teva Pharmaceuticals Inc.: Financials

Figure 47 Genesis Biotec Inc.: Financials

Figure 48 Mallinckrodt Pharmaceuticals: Financials

Figure 49 Abbott: Financials

Figure 50 Pfizer Inc.: Financials

Figure 51 Johnson & Johnson Services Inc.: Financials

Figure 52 Cipla: Financials

Figure 53 Dr. Reddy’s Laboratories Ltd.: Financials

Figure 54 Sanofi: Financials

세계 파라세타몰 시장 – 2024년 – 2031년

Global Paracetamol Market - 2024 - 2031